CN104447397B - 具抗癌活性的3,5-二溴水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 - Google Patents
具抗癌活性的3,5-二溴水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 Download PDFInfo
- Publication number
- CN104447397B CN104447397B CN201410829304.9A CN201410829304A CN104447397B CN 104447397 B CN104447397 B CN 104447397B CN 201410829304 A CN201410829304 A CN 201410829304A CN 104447397 B CN104447397 B CN 104447397B
- Authority
- CN
- China
- Prior art keywords
- schiff bases
- dibromosalicylaldehyde
- dibromosalicylaldehyde contracting
- ampd
- ampd schiff
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002262 Schiff base Substances 0.000 title claims abstract description 39
- -1 AMPD schiff bases Chemical class 0.000 title claims abstract description 38
- JHZOXYGFQMROFJ-UHFFFAOYSA-N 3,5-dibromo-2-hydroxybenzaldehyde Chemical compound OC1=C(Br)C=C(Br)C=C1C=O JHZOXYGFQMROFJ-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 101150035093 AMPD gene Proteins 0.000 title claims abstract description 35
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 7
- 230000015572 biosynthetic process Effects 0.000 title description 7
- 238000003786 synthesis reaction Methods 0.000 title description 7
- 239000013078 crystal Substances 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960000935 dehydrated alcohol Drugs 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 8
- 238000013461 design Methods 0.000 claims abstract description 6
- 238000010438 heat treatment Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000002425 crystallisation Methods 0.000 claims abstract description 4
- 230000008025 crystallization Effects 0.000 claims abstract description 4
- 229940079593 drug Drugs 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 238000010189 synthetic method Methods 0.000 claims abstract description 4
- 238000011275 oncology therapy Methods 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 5
- 229940126214 compound 3 Drugs 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 5
- 230000000259 anti-tumor effect Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- 210000004881 tumor cell Anatomy 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010005003 Bladder cancer Diseases 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 201000005112 urinary bladder cancer Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Br2-C2 | 1.890(10) | C8-C10 | 1.548(16) |
Br1-C4 | 1.908(11) | O3-C11 | 1.428(13) |
O1-C1 | 1.287(13) | N1-C7 | 1.334(14) |
O2-C10 | 1.410(14) | C5-C4 | 1.314(16) |
C3-C4 | 1.442(16) | C5-C6 | 1.451(16) |
C3-C2 | 1.328(17) | C2-C1 | 1.417(16) |
C8-C11 | 1.529(13) | C7-C6 | 1.386(15) |
C8-N1 | 1.450(15) | C1-C6 | 1.447(14) |
C8-C9 | 1.521(15) | C8-C10 | 1.548(16) |
Br2-C2 | 1.890(10) | O3-C11 | 1.428(13) |
Br1-C4 | 1.908(11) | N1-C7 | 1.334(14) |
O1-C1 | 1.287(13) | C5-C4-C3 | 120.9(10) |
C2-C3-C4 | 119.4(11) | C3-C2-Br2 | 118.5(9) |
C11-C8-C10 | 109.2(9) | C3-C2-C1 | 123.7(10) |
N1-C8-C11 | 108.3(9) | C1-C2-Br2 | 117.6(8) |
N1-C8-C9 | 112.3(10) | N1-C7-C6 | 121.9(9) |
N1-C8-C10 | 106.4(8) | O1-C1-C2 | 123.3(9) |
C9-C8-C11 | 112.5(9) | O1-C1-C6 | 120.2(10) |
C9-C8-C10 | 107.8(9) | C2-C1-C6 | 116.5(10) |
O3-C11-C8 | 112.1(8) | C7-C6-C5 | 117.4(9) |
C7-N1-C8 | 127.3(8) | C7-C6-C1 | 124.1(10) |
C4-C5-C6 | 121.2(10) | C1-C6-C5 | 118.4(10) |
C3-C4-Br1 | 116.6(9) | O2-C10-C8 | 109.0(9) |
C5-C4-Br1 | 122.4(8) |
BEL-7404 | HepG2 | HeLa | T-24 | HL-7702 |
35.27±1.15 | 30.43±1.02 | 26.91±1.60 | 40.05±1.66 | 35.97±1.14 |
BEL-7404 | HepG2 | HeLa | T-24 | HL-7702 |
81.23±1.03 | 112.91±0.69 | 162.65±3.62 | 30.31±1.81 | 95.36±3.65 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410829304.9A CN104447397B (zh) | 2014-12-26 | 2014-12-26 | 具抗癌活性的3,5-二溴水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410829304.9A CN104447397B (zh) | 2014-12-26 | 2014-12-26 | 具抗癌活性的3,5-二溴水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104447397A CN104447397A (zh) | 2015-03-25 |
CN104447397B true CN104447397B (zh) | 2016-04-06 |
Family
ID=52894231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410829304.9A Active CN104447397B (zh) | 2014-12-26 | 2014-12-26 | 具抗癌活性的3,5-二溴水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104447397B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106432284A (zh) * | 2016-09-13 | 2017-02-22 | 桂林理工大学 | 3,5‑二溴水杨醛缩‑2‑氨基‑2‑甲基‑1,3‑丙二醇席夫碱铜配合物及合成方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4073942A (en) * | 1972-10-23 | 1978-02-14 | Boehringer Ingelheim Gmbh | Halo-substituted hydroxybenzyl-amines as secretolytic agents |
-
2014
- 2014-12-26 CN CN201410829304.9A patent/CN104447397B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4073942A (en) * | 1972-10-23 | 1978-02-14 | Boehringer Ingelheim Gmbh | Halo-substituted hydroxybenzyl-amines as secretolytic agents |
Non-Patent Citations (2)
Title |
---|
Antitumour activities of some schiff bases derived from benzoin,salicylaldehyde, amino phenol and 2,4 dinitrophenyl hydrazine;M. Jesmin et al.;《Thai J. Pharm. Sci.》;20101231;第34卷;第21页第1段至第31页倒数第1段 * |
Biological Activities of Schiff Bases and Biological Activities of Schiff Bases and Their Complexes: A Review of Recent Works;Wail Al Zoubi;《International Journal of Organic Chemistry》;20131130;第3卷;第73页第1段至第95页倒数第1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN104447397A (zh) | 2015-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103976956B (zh) | 一种靶向抗肝癌纳米粒子及其制备方法和应用 | |
CN109796497A (zh) | 一种以2-乙酰基-3-乙基吡嗪缩氨基硫脲为配体的铋化合物及其合成方法 | |
CN104910196B (zh) | 一种手性四核铜基有机金属框架及其制备方法和应用 | |
CN104447397B (zh) | 具抗癌活性的3,5-二溴水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 | |
CN104650121A (zh) | 具抗癌活性的配合物[Zn(H2L2)2](H2O)5的合成及应用 | |
CN105693636B (zh) | 具抗癌活性的Cu(mtyp)2(H2O)2的合成及应用 | |
CN108558952A (zh) | 一种2-苯基吡啶双核钯(ii)配合物及其制备方法和应用 | |
CN104016957A (zh) | 7-甲基-3-香叶基黄酮和7-甲基-3-异戊烯基黄酮及其制备方法和应用 | |
CN104649930B (zh) | 具抗癌活性的配合物[Zn(H2L4)2].(H2O)的合成及应用 | |
CN104650157A (zh) | 具抗癌活性的配合物[Ni(H2L2)2](H2O)2的合成及应用 | |
CN104447766A (zh) | 一种配合物[Cu2(L12)2]·(H2O)的原位合成及抗肿瘤应用 | |
CN104402762B (zh) | 具抗癌活性的3,5-二氯水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 | |
CN103421048B (zh) | 一氯·二甲基亚砜·6-羟基氧化异阿朴啡合铂(ii)及其合成方法和应用 | |
CN104447399A (zh) | 具抗癌活性的甲氧基水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 | |
CN104447398A (zh) | 具抗癌活性的5-溴水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 | |
CN104402761A (zh) | 具抗癌活性的乙氧基水杨醛缩2-氨基-2-甲基-1,3-丙二醇希夫碱的合成及应用 | |
CN107488198B (zh) | 一种色胺酮铂配合物及其合成方法与应用 | |
CN104817535A (zh) | 一种喹啉酮衍生物及其合成方法及应用 | |
CN104725429A (zh) | 具抗癌活性的配合物Mn(H2L3)2的合成及应用 | |
CN104649931A (zh) | 具抗癌活性的配合物Mn(H2L4)2的合成及应用 | |
CN105037265A (zh) | 一类含查尔酮骨架的喹啉酮衍生物的制备方法及在抗癌药物中的应用 | |
CN104387423A (zh) | 以手性化合物为配体的铂(ii)配合物及其合成方法和应用 | |
CN104530098A (zh) | 单晶级[Cu2(L11)2]·(H2O)配合物的合成方法及作为抗癌药物应用 | |
CN104447817B (zh) | 一种配合物[[Cu2(L7)(L10)]的原位合成及作为抗癌药物的应用 | |
CN102977081B (zh) | 胡椒乙胺缩吡啶-2-甲醛及其合成方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201214 Address after: 11 / F, Jingang building, south of Lianyungang Road, Sheyang Economic Development Zone, Sheyang County, Yancheng City, Jiangsu Province 224300 Patentee after: Li Zaigao Address before: 541004 the Guangxi Zhuang Autonomous Region Guilin Construction Road No. 12 Patentee before: GUILIN University OF TECHNOLOGY |
|
TR01 | Transfer of patent right | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150325 Assignee: Yancheng Aipinyue Network Technology Co.,Ltd. Assignor: Li Zaigao Contract record no.: X2023980047070 Denomination of invention: Synthesis and application of 3,5-dibromosalicylic aldehyde 2-amino-2-methyl-1,3-propanediol Schiff base with anticancer activity Granted publication date: 20160406 License type: Common License Record date: 20231120 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Yancheng Aipinyue Network Technology Co.,Ltd. Assignor: Li Zaigao Contract record no.: X2023980047070 Date of cancellation: 20240416 |
|
EC01 | Cancellation of recordation of patent licensing contract |